Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Frontier Biotechnologies Inc.

Home Clinical Trial Sponsors and OrganizationsFrontier Biotechnologies Inc.

Frontier Biotechnologies Inc.

No.7 Building, No.5 Qiande Road, Jiangning District, Nanjing, 江苏省, China

Also known as:

frontier biotechnologies

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

13

1 active

Approvals

1

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

6

46.1%

Phase 2

6

46.1%

Phase 3

1

7.7%

Trial Status Distribution

Completed

7

53.9%

Not yet recruiting

1

7.7%

Recruiting

2

15.4%

Unknown

3

23.1%

Clinical Trials

Trials sponsored by this organization (13)

An Bioequivalence Study of Loxoprofen Sodium Patches in Healthy Volunteers

Not yet recruiting

Jul 202440 participants

Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19

Jan 20231,336 participants

A Study of FB2001 for Inhalation in Healthy Chinese Adults

Oct 202232 participants

Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)

Sep 20221,188 participants

Study to Evaluate Pharmacokinetic and Safety of Albuvirtide Between Intravenous Drip and Intravenous Injection

Feb 202230 participants

A Bridging Study of FB2001 in Healthy Subjects

Dec 202140 participants

Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 Infection

Nov 202120 participants

Albuvirtide in Combination With 3BNC117 in Virologically Suppressed Subjects With HIV-1 Infection

May 202124 participants

Page 1 of 2

Approvals

Approvals by Agency

NPRA

National Pharmaceutical Regulatory Agency

1

Approvals

Recent Approvals

AIKENING (Albuvirtide for Injection 160 mg/vial)

News

No news articles found

On this page

Overview
Clinical Trials13
Approvals1
News

Back to Organizations